Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 272

1.

Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine.

Elberse KE, van der Heide HG, Witteveen S, van de Pol I, Schot CS, van der Ende A, Berbers GA, Schouls LM.

Vaccine. 2012 Dec 14;30(52):7644-51. doi: 10.1016/j.vaccine.2012.04.021. Epub 2012 Apr 19.

PMID:
22521844
[PubMed - indexed for MEDLINE]
2.

Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.

Pichon B, Ladhani SN, Slack MP, Segonds-Pichon A, Andrews NJ, Waight PA, Miller E, George R.

J Clin Microbiol. 2013 Mar;51(3):820-7. doi: 10.1128/JCM.01917-12. Epub 2012 Dec 26.

PMID:
23269742
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Population structure of invasive Streptococcus pneumoniae in The Netherlands in the pre-vaccination era assessed by MLVA and capsular sequence typing.

Elberse KE, van de Pol I, Witteveen S, van der Heide HG, Schot CS, van Dijk A, van der Ende A, Schouls LM.

PLoS One. 2011;6(5):e20390. doi: 10.1371/journal.pone.0020390. Epub 2011 May 26.

PMID:
21637810
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods.

Yildirim I, Stevenson A, Hsu KK, Pelton SI.

Pediatr Infect Dis J. 2012 Oct;31(10):1016-21. doi: 10.1097/INF.0b013e3182615615.

PMID:
22673142
[PubMed - indexed for MEDLINE]
5.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
[PubMed - indexed for MEDLINE]
6.

Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.

Mokaddas E, Albert MJ.

Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061.

PMID:
23228356
[PubMed - indexed for MEDLINE]
7.

Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW.

Clin Infect Dis. 2009 Jul 15;49(2):205-12. doi: 10.1086/599827.

PMID:
19508165
[PubMed - indexed for MEDLINE]
Free Article
8.

Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel.

Ben-Shimol S, Greenberg D, Givon-Lavi N, Elias N, Glikman D, Rubinstein U, Dagan R; Israeli Bacteremia and Meningitis Active Surveillance Group.

Vaccine. 2012 Oct 12;30(46):6600-7. doi: 10.1016/j.vaccine.2012.08.012. Epub 2012 Aug 30.

PMID:
22939907
[PubMed - indexed for MEDLINE]
9.

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012.

Demczuk WH, Martin I, Griffith A, Lefebvre B, McGeer A, Lovgren M, Tyrrell GJ, Desai S, Sherrard L, Adam H, Gilmour M, Zhanel GG; Toronto Bacterial Diseases Network; Canadian Public Health Laboratory Network.

Can J Microbiol. 2013 Dec;59(12):778-88. doi: 10.1139/cjm-2013-0614. Epub 2013 Oct 21.

PMID:
24313450
[PubMed - indexed for MEDLINE]
10.

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; Oxford Invasive Pneumococcal Surveillance Group.

J Med Microbiol. 2008 Apr;57(Pt 4):480-7. doi: 10.1099/jmm.0.47690-0.

PMID:
18349369
[PubMed - indexed for MEDLINE]
Free Article
11.

Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain.

Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease.

J Infect. 2011 Aug;63(2):151-62. doi: 10.1016/j.jinf.2011.06.002. Epub 2011 Jun 12.

PMID:
21679725
[PubMed - indexed for MEDLINE]
12.

Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.

Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ, Santosham M, Craig MJ, O'Brien KL.

Clin Infect Dis. 2008 Aug 15;47(4):476-84. doi: 10.1086/590001.

PMID:
18627249
[PubMed - indexed for MEDLINE]
Free Article
13.

Epidemiologic characteristics, serotypes, and antimicrobial susceptibilities of invasive Streptococcus pneumoniae isolates in a nationwide surveillance study in Lebanon.

Hanna-Wakim R, Chehab H, Mahfouz I, Nassar F, Baroud M, Shehab M, Pimentel G, Wasfy M, House B, Araj G, Matar G, Dbaibo G; Lebanese Inter-Hospital Pneumococcal Surveillance Program.

Vaccine. 2012 Dec 31;30 Suppl 6:G11-7. doi: 10.1016/j.vaccine.2012.07.020.

PMID:
23228352
[PubMed - indexed for MEDLINE]
14.

Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.

Isaacman DJ, McIntosh ED, Reinert RR.

Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Review.

PMID:
19700359
[PubMed - indexed for MEDLINE]
Free Article
15.

Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.

Motlova J, Benes C, Kriz P.

Epidemiol Infect. 2009 Apr;137(4):562-9. doi: 10.1017/S0950268808001301. Epub 2008 Sep 16.

PMID:
18796171
[PubMed - indexed for MEDLINE]
16.

Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.

Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr.

Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.

PMID:
19949357
[PubMed - indexed for MEDLINE]
17.

Pneumococcal disease in South Australia: vaccine success but no time for complacency.

Johnson DR, D'Onise K, Holland RA, Raupach JC, Koehler AP.

Vaccine. 2012 Mar 9;30(12):2206-11. doi: 10.1016/j.vaccine.2011.12.119. Epub 2012 Jan 23.

PMID:
22273663
[PubMed - indexed for MEDLINE]
18.

Invasive pneumococcal disease a decade after pneumococcal conjugate vaccine use in an American Indian population at high risk for disease.

Weatherholtz R, Millar EV, Moulton LH, Reid R, Rudolph K, Santosham M, O'Brien KL.

Clin Infect Dis. 2010 May 1;50(9):1238-46. doi: 10.1086/651680.

PMID:
20367225
[PubMed - indexed for MEDLINE]
Free Article
19.

Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.

Ingels H, Rasmussen J, Andersen PH, Harboe ZB, Glismann S, Konradsen H, Hoffmann S, Valentiner-Branth P, Lambertsen L; Danish Pneumococcal Surveillance Collaboration Group 2009-2010.

Vaccine. 2012 Jun 6;30(26):3944-50. doi: 10.1016/j.vaccine.2012.03.060. Epub 2012 Apr 11.

PMID:
22504662
[PubMed - indexed for MEDLINE]
20.

Eradication of invasive pneumococcal disease due to the seven-valent pneumococcal conjugate vaccine serotypes in Calgary, Alberta.

Leal J, Vanderkooi OG, Church DL, Macdonald J, Tyrrell GJ, Kellner JD.

Pediatr Infect Dis J. 2012 Sep;31(9):e169-75.

PMID:
22673137
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk